Harmony Biosciences Holdings, Inc. Profile Avatar - Palmy Investing

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive day…
Biotechnology
US, Plymouth Meeting [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of Harmony Biosciences Holdings, Inc.

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
- -% Yield
0.00% Payout Ratio
End of HRMY's Analysis
CIK: 1802665 CUSIP: 413197104 ISIN: US4131971040 LEI: - UEI: -
Secondary Listings
HRMY has no secondary listings inside our databases.